Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years: long-term data from the future 1 and future 2 studies

L Gossec, TK Kvien, PG Conaghan, M Østergaard, D Gladman, P Mease, L Rasouliyan, L Pricop, C Gaillez, S Jugl

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerSAT0463 
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind76
Udgave nummerSuppl 2
Sider (fra-til)949
ISSN0003-4967
DOI
StatusUdgivet - 2017

Citationsformater